{"filing":{"accession_number":"0001193125-26-328716","cik":"0001563577","ticker":"GRTX","company_name":"Galera Therapeutics, Inc.","form":"8-K","filing_date":"2026-07-31","report_date":"2026-07-31","primary_document":"d138144d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1563577/000119312526328716/d138144d8k.htm"},"events":[{"id":22438,"run_id":20298,"accession_number":"0001193125-26-328716","anchor_item_number":"3.02","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"Galera completed a private placement of Series C Non-Voting Convertible Preferred Stock to qualified institutional buyers and accredited investors, raising approximately $350.0 million in gross proceeds under Section 4(a)(2) exemption from registration.","company_name":"Galera Therapeutics, Inc.","ticker":"GRTX","filing_date":"2026-07-31","form":"8-K","submitted_at":null,"items":[{"id":22378,"accession_number":"0001193125-26-328716","item_number":"3.02","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Galera completed a private placement of Series C Non-Voting Convertible Preferred Stock to qualified institutional buyers and accredited investors, raising approximately $350.0 million in gross proceeds. The shares were issued under Section 4(a)(2) exemption from registration, which is the hallmark of a dilutive private placement (PIPE). This is a material capital-raising event that would significantly affect investor assessment of the company's capitalization and ownership structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-01T00:19:53.317306+00:00","company_name":"","ticker":null,"filing_date":""}]},{"id":22439,"run_id":20298,"accession_number":"0001193125-26-328716","anchor_item_number":"7.01","event_type":"dividend_distribution","event_domain":"financial","is_material":true,"confidence":0.85,"summary":"Galera declared a distribution of contingent value rights (CVRs) to holders of common stock as of July 31, 2026, with distribution expected August 6, 2026, representing contingent cash payments tied to future asset dispositions.","company_name":"Galera Therapeutics, Inc.","ticker":"GRTX","filing_date":"2026-07-31","form":"8-K","submitted_at":null,"items":[{"id":22379,"accession_number":"0001193125-26-328716","item_number":"7.01","item_title":null,"event_type":"dividend_distribution","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"Galera has declared a distribution of contingent value rights (CVRs) to holders of common stock as of a specified record date (July 31, 2026), with distribution expected August 6, 2026. This is a formal declaration and distribution of rights to shareholders, fitting the dividend_distribution category. The CVRs represent contingent cash payments tied to future asset dispositions, making this a material capital distribution event in connection with the pending merger closing.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-01T00:19:53.317306+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":22378,"accession_number":"0001193125-26-328716","item_number":"3.02","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Galera completed a private placement of Series C Non-Voting Convertible Preferred Stock to qualified institutional buyers and accredited investors, raising approximately $350.0 million in gross proceeds. The shares were issued under Section 4(a)(2) exemption from registration, which is the hallmark of a dilutive private placement (PIPE). This is a material capital-raising event that would significantly affect investor assessment of the company's capitalization and ownership structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-01T00:19:53.317306+00:00","company_name":"Galera Therapeutics, Inc.","ticker":"GRTX","filing_date":"2026-07-31"},{"id":22379,"accession_number":"0001193125-26-328716","item_number":"7.01","item_title":null,"event_type":"dividend_distribution","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"Galera has declared a distribution of contingent value rights (CVRs) to holders of common stock as of a specified record date (July 31, 2026), with distribution expected August 6, 2026. This is a formal declaration and distribution of rights to shareholders, fitting the dividend_distribution category. The CVRs represent contingent cash payments tied to future asset dispositions, making this a material capital distribution event in connection with the pending merger closing.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-01T00:19:53.317306+00:00","company_name":"Galera Therapeutics, Inc.","ticker":"GRTX","filing_date":"2026-07-31"}]}